Why are tumours dependent on the MYC oncoprotein?
Add to your list(s)
Download to your calendar using vCal
If you have a question about this talk, please contact .
Description: Cancers arise when cell-signalling pathways, which are normally tightly regulated, become disrupted. Tumours subsequently become dependent on the expression of certain proteins, sometimes referred to as “oncogene addiction”. Identification of these tumour-specific vulnerabilities, absent from normal cells, provides a therapeutic window. In this talk, I provide molecular rationales on how inhibition of the MYC oncoprotein, deregulated in most if not all human cancers, leads to the regression of a multitude of tumour types (including lung, pancreas and mammary).
This talk is part of the Seminars at the Department of Biochemistry series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
|